300
Participants
Start Date
June 21, 2022
Primary Completion Date
February 28, 2027
Study Completion Date
February 28, 2029
Observation
No intervention
RECRUITING
Cancer Care Associates of York, York
RECRUITING
The Center for Cancer and Blood Disorders, Bethesda
RECRUITING
Southeastern Medical Oncology Center, Goldsboro
RECRUITING
Ohio State University, Columbus
RECRUITING
OhioHealth Research Institute, Columbus
RECRUITING
Toledo Clinic Cancer Center, Toledo
RECRUITING
Aultman Hospital, Canton
RECRUITING
TriHealth Cancer Institute, Cincinnati
RECRUITING
ThedaCare Regional Cancer Center, Appleton
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Mercy Clinic Oncology and Hematology - Sindelar Cancer Center, St Louis
RECRUITING
Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center, St Louis
RECRUITING
Mercy Clinic Oncology and Hematology - Joplin, Joplin
RECRUITING
Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield
RECRUITING
Nebraska Cancer Specialists, Omaha
RECRUITING
Mercy Clinic Oncology - Fort Smith, Fort Smith
RECRUITING
Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
RECRUITING
Utah Cancer Specialists, Salt Lake City
RECRUITING
MemorialCare, Fountain Valley
RECRUITING
University of Washington / Fred Hutchinson Cancer Center, Seattle
Tempus AI
INDUSTRY